There are various reasons to choose cord blood banking, but one of the significant reasons is that it helps to protect your baby from more than 80 diseases. And the number is expected to continue to grow. Beyond the current treatments, clinical trials for using cord blood in strokes, heart disease, diabetes and many other regenerative therapies are underway.
Cryoviva India allows you to give your baby the gift of a lifetime with stem cell banking in India. Cryoviva, as a company, aims at providing high-quality umbilical cord blood banking preservation for both private and public donation purposes. They use high-end processing and storage technology that International authorities have approved. In addition, Cryoviva follows the “Closed bag” collection method for harvesting the cord blood stem cells. This reduces the possibility of contamination of cord blood significantly.
Let’s look at why you should opt for stem cell banking other than the advantage it provides in the treatment of more than 80 diseases.
Easy to Collect
The stem cell collection process is performed easily at the same time when the umbilical cord is cut. And it causes no pain or risk to the mother or baby during the extraction of the blood. On the other hand, when collected from bone marrow, stem cells require an invasive surgical procedure where general anaesthesia is given, which comes with inherent risks.
Better Matching
For successful transplantation of stem cells, there has to be a perfect match for the receiver & donor. However, matched stem cells can be found in some public databases, but the chance of finding an ideal partner is very low, and complications may arise with unrelated blood transfusions. Whereas genetically related stem cells extracted from the umbilical cord blood banking more often result in a successful transplant for siblings and other blood-related family members.
Therefore, this implies that a child’s cord blood stem cells, if there’s a need, could one day be used to help not just their siblings but parents as well.
Less Risk of Post-Transplant Complications
Apart from being better accepted entirely by the body, cord blood stem cells significantly reduce the risk of post-transplant graft-versus-host disease (GVHD). GVHD is when the transplanted cells attack or harm the body. It is one of the significant complications of stem cell transplants. The risk of GVHD post stem cell transplant depends on the relationship between the donor & the receiver. According to the report of the National Institute of Health:
- Identical twins have a meagre chance of suffering from GVHD
- Blood-related family members have about 35%–45% chance of GVHD
- Unrelated donor & receiver has about 60%–80% chance of GVHD
Besides, cord blood banking stem cells are better accepted by the body as they’ve rarely been contaminated with latent viruses, which is not valid for stem cells from other sources. Therefore, cord blood stem cell banking has been dubbed “privileged” as they haven’t been exposed to many diseases.
